JENNIFER BURNS: Open Payments
NPI 1063924660 · BURLINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $94 · 2025 $301
Food & beverage: $216Education: $85
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 1 | $85 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| GENZYME CORPORATION | 1 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Genmab U.S., Inc. | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| ARRAY BIOPHARMA INC | 1 | $21 |
Products named: KEYTRUDA, SARCLISA, KISQALI, Tivdak, OJJAARA, REBLOZYL, LORBRENA.
Industry payments across NC — which companies pay providers there.
